AiPrise | $12,500,000 | (Oct 10, 2025)
Glue(US) | $20,000,000 | (Oct 10, 2025)
Arthrosi Therapeutics, Inc. | $153,000,000 | (Oct 10, 2025)
Asterix Foods
Israel
- Tel Aviv
- 10/10/2025
- Seed
- $4,200,000
Industry leading companies like Impossible, Perfect Day (RebelBio), and EVERY (IndieBio) have shown the powerful commercial appeal of animal-free proteins. Behind this first wave comes a second wave: glycoproteins.
Glycoproteins require precise glycosylations to accurately fold, recognize, and bind – driving functional performance needed in the food industry. To unlock this second wave of animal-free proteins, Asterix Foods is using plant cells, because plant cells can easily achieve glycosylations that microbial fermentation is challenged by.
- Industry Biotechnology
- Website https://www.asterixfoods.com/
- LinkedIn https://www.linkedin.com/company/asterix-foods/
Related People
Dan EvenFounder
Israel -
Tel Aviv District
Experienced in Molecular Biology, Plant Genetic Engineering, and Plant Biology.
Specializing in: Research and Development, Biotechnology, Molecular Biology, Alternative Food & Protein, Plant Biology, Plant Genetic Engineering, Protein Purification & Expression, Antibody Engineering, Microbiology.
Nilo Therapeutics | $101,000,000 | (Oct 10, 2025)
Vulcan Technologies | $10,900,000 | (Oct 10, 2025)
Affinia Therapeutics | $40,000,000 | (Oct 10, 2025)
Knapsack | $10,000,000 | (Oct 10, 2025)
Search Party | $3,500,000 | (Oct 10, 2025)
enurgen | $4,100,000 | (Oct 10, 2025)
Echelon AI | $4,750,000 | (Oct 10, 2025)
FurtherAI | $25,000,000 | (Oct 10, 2025)